Close Menu

A Pocket-Sized Lab

People living in remote areas of developing nations are often struck with diseases that are preventable or curable, says the Guardian's GrrlScientist. Unfortunately, they often can't get to places where they could be treated. So now, in a "brilliant cross-pollination of engineering, physics and biology," researchers have developed a pocket-sized microfluidics-based device that can accurately diagnose syphilis and HIV in minutes, in any location, GrrlScientist says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.